China's medical products administrator approved North China Pharmaceutical's (SHA:600812) vancomycin hydrochloride injection, according to a Wednesday filing with the Shanghai bourse.
The antibiotic injection is used for anti-bacterial infections, including sepsis, endocarditis, osteomyelitis, and others, the drug company said in its filing.
Shares fell 1% during afternoon trading on Wednesday.